NDLI: Community oncologists’ perceptions and utilization of large-panel genomic tumor testing

Content Provider	Springer Nature : BioMed Central
Author	Anderson, Eric C. Hinton, Alexandra C. Lary, Christine W. Fenton, Anny T. H. R. Antov, Andrey Edelman, Emily Helbig, Petra Reed, Kate Miesfeldt, Susan Thomas, Christian A. Hall, Michael J. Roberts, J. Scott Rueter, Jens Han, Paul K. J.
Abstract	Purpose Large-panel genomic tumor testing (GTT) is an emerging technology with great promise but uncertain clinical value. Previous research has documented variability in academic oncologists’ perceptions and use of GTT, but little is known about community oncologists’ perceptions of GTT and how perceptions relate to clinicians' intentions to use GTT. Methods Community oncology physicians (N = 58) participating in a statewide initiative aimed at improving access to large-panel GTT completed surveys assessing their confidence in using GTT, attitudes regarding the value of GTT, perceptions of barriers to GTT implementation, and future intentions to use GTTs. Descriptive and multivariable regression analyses were conducted to characterize these perceptions and to explore the relationships between them. Results There was substantial variability in clinicians’ perceptions of GTT. Clinicians generally had moderate confidence in their ability to use GTT, but lower confidence in patients’ ability to understand test results and access targeted treatment. Clinicians had positive attitudes regarding the value of GTT. Clinicians’ future intentions to use GTT were associated with greater confidence in using GTT and greater perceived barriers to implementing GTT, but not with attitudes about the value of GTT. Conclusions Community oncologists’ perceptions of large-panel genomic tumor testing are variable, and their future intentions to use GTT are associated with both their confidence in and perceived barriers to its use, but not with their attitudes towards GTT. More research is needed to understand other factors that determine how oncologists perceive and use GTT in clinical practice.
Related Links	https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-021-08985-0.pdf
Ending Page	9
Page Count	9
Starting Page	1
File Format	HTM / HTML
ISSN	14712407
DOI	10.1186/s12885-021-08985-0
Journal	BMC Cancer
Issue Number	1
Volume Number	21
Language	English
Publisher	BioMed Central
Publisher Date	2021-11-25
Access Restriction	Open
Subject Keyword	Cancer Research Oncology Surgical Oncology Health Promotion and Disease Prevention Biomedicine Medicine Public Health Genomic Cancer Uncertainty Attitudes Confidence Medicine/Public Health
Content Type	Text
Resource Type	Article
Subject	Cancer Research Oncology Genetics
Journal Impact Factor	3.4/2023
5-Year Journal Impact Factor	3.8/2023

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Oncologists’ perceptions of tumor genomic profiling and barriers to communicating secondary hereditary risks to African American cancer patients

Metastatic breast cancer patient perceptions of somatic tumor genomic testing

Patient perspectives on molecular tumor profiling: “Why wouldn’t you?”

Efficient mutation screening for cervical cancers from circulating tumor DNA in blood

Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations

Genomic investigation of innate sensing pathways in the tumor microenvironment

Characterization of the genomic landscape in liver oligometastatic NSCLC

Testing of human papillomavirus in lung cancer and non-tumor lung tissue

Allelotyping identification of genomic alterations in rectal chromosomally unstable tumors without preoperative treatment

Community oncologists’ perceptions and utilization of large-panel genomic tumor testing

Similar Documents

Oncologists’ perceptions of tumor genomic profiling and barriers to communicating secondary hereditary risks to African American cancer patients

Metastatic breast cancer patient perceptions of somatic tumor genomic testing

Patient perspectives on molecular tumor profiling: “Why wouldn’t you?”

Efficient mutation screening for cervical cancers from circulating tumor DNA in blood

Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations

Genomic investigation of innate sensing pathways in the tumor microenvironment

Characterization of the genomic landscape in liver oligometastatic NSCLC

Testing of human papillomavirus in lung cancer and non-tumor lung tissue

Allelotyping identification of genomic alterations in rectal chromosomally unstable tumors without preoperative treatment

Community oncologists’ perceptions and utilization of large-panel genomic tumor testing